Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formulated PSTA vs PSTA Alone in Macular Edema Secondary to Non-ischemic RVO
NCT05385562Completed
- Sponsor
- Al-Azhar University
- Start
- Jan 2020
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Trial of triamcinolone acetonide in macular edema (2 arms), sponsored by Al-Azhar University. Primary endpoints: Best-corrected visual acuity at 6 months and Central macular thickness at 6 months. Started Jan 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT05385562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05385562.